Houston, TX 的 血液疾病 臨床試驗
9 項針對 血液疾病 的研究正在 Houston（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
招募中3 期
- Texas Childrens Cancer and Hematology Center, Houston
- U of TX Health Science Ct, Houston
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
招募中3 期
- Quetzal Site 6, Houston
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
招募中3 期
- Baylor College of Medicine, Houston
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
招募中2 期
- The University of Texas MD Anderson Cancer Center, Houston
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
招募中3 期
- Baylor College of Medicine, Houston
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
招募中觀察性研究
- Gulf States Hemophilia and Thrombophilia Center, Houston
- Texas Children's Hemophilia & Thrombosis Center/Baylor College of Medicine, Houston
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
招募中2/3 期
- MD Anderson Cancer Center, Houston
Leading in MPNs Beyond Ruxolitinib in Combo With T-Regs
招募中1 期
- The University of Texas MD Anderson Cancer Center, Houston
Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies
招募中1 期
- MD Anderson Cancer Center, Houston
其他城市的 血液疾病 試驗
- Boston, MA10 項研究
- Atlanta, GA10 項研究
- Los Angeles, CA9 項研究
- The Bronx, NY8 項研究
- New York City, NY7 項研究
- Nashville, TN7 項研究
- Mountain View, CA6 項研究
- Durham, NC5 項研究
- Portland, OR5 項研究
- Washington, DC5 項研究
- Seattle, WA5 項研究
- Greenville, NC5 項研究
Houston 的其他研究
- 非小細胞肺癌145 項研究
- 乳癌126 項研究
- 癌症（所有類型）121 項研究
- 轉移性癌症104 項研究
- 大腸直腸癌102 項研究
- 卵巢癌89 項研究
- 急性髓系白血病85 項研究
- 肺癌78 項研究
- 前列腺癌76 項研究
- 子宮內膜癌68 項研究
- 胰臟癌61 項研究
- 黑色素瘤59 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月5日。各研究自行設定資格標準；由研究團隊決定參與者資格。